Barry D. Quart, Director at Kiniksa Pharmaceuticals International, plc (KNSA), sold 40,258 shares at $41.51 ($1.7M) on 2025-12-15, disclosed to the SEC on 2025-12-17.
Scheduled sale ($1.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.51 | 20,129 | $836K | 50.0% |
| 2 | $41.51 | 20,129 | $836K | 50.0% |
| Total | $41.51 avg | 40,258 | $1.7M | 100% |
| Filing → |
| KNSA | SELL | 2026-02-12 | $126K | — | Filing → |
| KNSA | SELL | 2026-02-04 | $722K | — | Filing → |
| KNSA | SELL | 2025-06-11 | $1.5M | — | Filing → |